NICE overturns previous decision, recommends Merck and Pfizer’s Bavencio
Pharma Times
APRIL 11, 2022
Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients
Pharma Times
APRIL 11, 2022
Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients
pharmaphorum
APRIL 12, 2022
The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. The Department of Health, NHS England and NICE have completed an evaluation of two new antibiotics – Pfizer’s Zavicefta (ceftazidime/avibactam) and Shionogi’s Fetcroja (cefiderocol) – that will be paid for using the new subscription-like model likened to a Netflix account.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Times
APRIL 15, 2022
The more rapidly we are able to produce safe, effective drugs for quick-spreading pathogens like the coronavirus, the more lives we can save.
Drug Channels
APRIL 12, 2022
The econowonks at the Centers for Medicare & Medicaid Services (CMS) recently released the latest projections for U.S. spending on healthcare. (See links below.) These data provide our first official look at post-pandemic U.S. healthcare spending. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharma Times
APRIL 13, 2022
Cantourage has appointed cannabis prescribers and is now officially operational via a new centre
pharmaphorum
APRIL 11, 2022
In an interview with Dudley Tabakin (CEO, VivoSense), Chris Garabedian (CEO, Xontogeny) and Tanja Dowe (CEO, Debiopharm Innovation Fund), pharmaphorum discusses the recent announcement of the closing of a $25 million Series A financing round to scale up the innovative VivoSense® software, which uses wearable sensor data in clinical trials, and for the development of novel digital biomarkers.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Outsourcing Pharma
APRIL 14, 2022
The US agencyâs latest draft document lays out guidelines to help increase involvement of underrepresented ethnic and racial populations in clinical research.
Pharma Times
APRIL 14, 2022
Approval demonstrates significant step forward in the treatment of adult advanced NSCLC patients with METex14
pharmaphorum
APRIL 11, 2022
GripAble has raised $11 million in first-round financing that will be used to advance its digital health approach to rehabilitation for people with neurological and musculoskeletal conditions on the international stage. The London, UK-based company has developed a platform that combines a hand-held sensor, gamified mobile app software, and telehealth consultations with therapists, which is designed to entertain users while they train at home.
NY Times
APRIL 11, 2022
The chemical derived from psychedelic mushrooms helped alleviate symptoms of depression and generated detectable neural responses that lasted weeks.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Channels
APRIL 15, 2022
Today’s guest post comes from Megan Marchal, Director of Specialty Pharmacy Strategy at CoverMyMeds. Megan discusses the access and affordability challenges faced by specialty therapy patients. She describes how CoverMyMeds’ centralized technology solutions—paired with experts familiar with each therapy—help patients navigate these challenges. And, she shares one patient’s personal journey.
Pharma Times
APRIL 11, 2022
The biologics development and manufacturing facility is currently under construction near Oxford, UK
pharmaphorum
APRIL 12, 2022
Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell us about a two-phase research study the companies recently performed to understand a patient’s prescription journey and who influences prescription-based decisions. The healthcare landscape has shifted dramatically due to the pandemic.
Outsourcing Pharma
APRIL 12, 2022
A recent online event hosted by the patient services company invited a number of women to share their experience and insights working in the research field.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Drug Channels
APRIL 11, 2022
Informa Connect's Life Sciences Commercial Contracts & Chargebacks 2022 Hybrid. May 24-25, 2022 | Philadelphia, PA www.informaconnect.com/contracts-chargebacks. Save 10% by using code 22DC10. The Life Sciences Commercial Contracts and Chargebacks conference returns as a hybrid event May 24-25 with the options of attending in-person in Philadelphia or virtually.
Pharma Times
APRIL 12, 2022
Engetix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD
pharmaphorum
APRIL 12, 2022
Novartis has joined the select cadre of drugmakers developing KRAS inhibitors for cancer, opening its account with phase 1b data on JDQ443 showing efficacy in KRAS-mutated non-small cell lung cancer (NSCLC). The results – presented at the American Association of Cancer Research (AACR) congress – set Novartis off in pursuit of Amgen, whose Lumakras (sotorasib) is already on the market, and Mirati Therapeutics which has adagrasib under review by the FDA.
Drug Patent Watch
APRIL 13, 2022
This chart shows the drugs with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
APRIL 12, 2022
Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.
Pharma Times
APRIL 14, 2022
Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer
pharmaphorum
APRIL 13, 2022
Training can be a bore; dull, predictable sessions shoe-horned into the diary when a meeting room is available or via a virtual session full of muted moments and cross-talk confusion. The pharma industry has turned the microscope of every aspect of its delivery in the face of era-defining shifts caused by the pandemic, and now it is time focus on coaching staff to perform across a new sales and information-sharing landscape.
Drug Patent Watch
APRIL 14, 2022
Annual Drug Patent Expirations for ARISTADA Aristada is a drug marketed by Alkermes Inc and is included in two NDAs. It is available from one supplier. There are fifteen patents…. The post New patent for Alkermes Inc drug ARISTADA appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Eye on FDA
APRIL 13, 2022
We are four months into the year, and this week OPDP has issued its fourth regulatory action letter of 2022. Two of the previous were Warning Letters, considered the more serious of the two categories, and two, including the latest, were Untitled Letters. As noted in past updates, FDA’s OPDP enforcement letters have dropped off considerably over the years.
Pharma Times
APRIL 12, 2022
Novacyt’s second direct-to-PCR test is the third product to be added to the Coronavirus Test Device Approvals (CTDA) register of approved products
pharmaphorum
APRIL 14, 2022
The massive backlog in patient care across Europe resulting from the pandemic will take at least three years to clear and in some cases as long as six years, says a new study. The research from Censuswide stems from surveys of oncologists and surgeons across six European countries, which found that 20% of them estimate clearing the backlog will take between four and six years.
NY Times
APRIL 11, 2022
Eric Adams tested positive after a series of public events promoting his first 100 days as mayor. He reminded eligible New Yorkers to take antivirals.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Drug Patent Watch
APRIL 11, 2022
This chart shows the drugs with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical drugs have the most drug patents in Hong Kong? appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
APRIL 13, 2022
Companies will support a study which provides vital information on arthritis for patient-supporting HCPs
pharmaphorum
APRIL 14, 2022
Pfizer’s Australian unit has tabled an offer to buy ResApp Health and its smartphone apps for the management and diagnosis of respiratory diseases in a deal that values the digital health company at around A$100 million (around $75 million). Pfizer is offering A$0.115 per share in cash for ResApp, a deal which has been accepted by the company’s directors and recommended to shareholders ahead of a vote scheduled in June.
NY Times
APRIL 11, 2022
We may feature your response in the Coronavirus Briefing newsletter.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Let's personalize your content